Literature DB >> 29532445

Combinatorial Preconditioning of Rat Brain Cultures with Subprotective Ethanol and Resveratrol Concentrations Promotes Synergistic Neuroprotection.

N Khodaie1, N Tajuddin1, R M Mitchell2, E J Neafsey1, M A Collins3.   

Abstract

Preconditioning brain cultures with moderate concentrations of ethanol (EtOH) or trans-resveratrol (RES), key red wine constituents, can prevent amyloid-β (Aβ) neurotoxicity. Past studies have indicated that moderate EtOH activates synaptic N-methyl-D-aspartate receptors (NMDAR) that, in part, signal via protein kinase C (PKC) to increase protective antioxidant proteins such as peroxiredoxin-2 (Prx2). RES preconditioning also is reported to involve NMDAR and PKC. However, although moderate, the EtOH and RES concentrations used have been noticeably above circulating levels from two glasses of wine, a daily intake linked to reduced risk of cognitive decline among older social drinkers. Given their mechanistic parallels, we speculated that subprotective EtOH and RES concentrations in a combinatorial preconditioning paradigm might elicit synergistic neuroprotection. To examine this notion, rat cerebellar cultures were pretreated with 10 mM EtOH (circulating concentration after ~ 2 drinks), 5 μM RES, EtOH + RES combinatorially, or media alone (controls). After 3 days, media were removed, and fresh media aliquots containing Aβ25-35 (25 μM) were added. Assessing apoptosis 24 h later with Hoescht 33342, neurodegeneration did not differ from controls in cultures separately preconditioned with 10 mM EtOH or 5 μM RES. However, apoptosis was prevented in combinatorially preconditioned cultures. Also, immunoblotting revealed elevated Prx2 levels due to combinatorial pretreatment that correlated with subsequent neuroprotection, whereas Prx2 was unchanged in separately pretreated cultures. Although the protective mechanisms require clarification, synergistically upregulated NMDAR-PKC-Prx2 (and other antioxidant proteins) is a reasonable component. These findings imply that EtOH + RES antioxidant synergy could be involved in neurobenefits attributed to low-moderate wine consumption.

Entities:  

Keywords:  Alcohol; Amyloid-β; Antioxidant; Neurodegeneration; Neurotoxicity; Peroxiredoxin

Mesh:

Substances:

Year:  2018        PMID: 29532445     DOI: 10.1007/s12640-018-9886-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  31 in total

Review 1.  Ethanol and oxidative stress.

Authors:  A Y Sun; M Ingelman-Sundberg; E Neve; H Matsumoto; Y Nishitani; Y Minowa; Y Fukui; S M Bailey; V B Patel; C C Cunningham; T Zima; L Fialova; L Mikulikova; P Popov; I Malbohan; M Janebova; K Nespor; G Y Sun
Journal:  Alcohol Clin Exp Res       Date:  2001-05       Impact factor: 3.455

Review 2.  Resveratrol and ischemic preconditioning in the brain.

Authors:  Ami P Raval; Hung Wen Lin; Kunjan R Dave; R Anthony Defazio; David Della Morte; Eun Joo Kim; Miguel A Perez-Pinzon
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

3.  Alcohol consumption and dementia risk: a dose-response meta-analysis of prospective studies.

Authors:  Wei Xu; Huifu Wang; Yu Wan; Chenchen Tan; Jieqiong Li; Lan Tan; Jin-Tai Yu
Journal:  Eur J Epidemiol       Date:  2017-01-17       Impact factor: 8.082

4.  Human immunodeficiency virus type 1 gp120 and ethanol coexposure in rat organotypic brain slice cultures: Curtailment of gp120-induced neurotoxicity and neurotoxic mediators by moderate but not high ethanol concentrations.

Authors:  A Belmadani; E J Neafsey; M A Collins
Journal:  J Neurovirol       Date:  2003-02       Impact factor: 2.643

Review 5.  Effects of moderate alcohol consumption on the central nervous system.

Authors:  M J Eckardt; S E File; G L Gessa; K A Grant; C Guerri; P L Hoffman; H Kalant; G F Koob; T K Li; B Tabakoff
Journal:  Alcohol Clin Exp Res       Date:  1998-08       Impact factor: 3.455

6.  Essential involvement of the NMDA receptor in ethanol preconditioning-dependent neuroprotection from amyloid-betain vitro.

Authors:  Robert M Mitchell; Edward J Neafsey; Michael A Collins
Journal:  J Neurochem       Date:  2009-08-19       Impact factor: 5.372

7.  Ethanol preconditioning of rat cerebellar cultures targets NMDA receptors to the synapse and enhances peroxiredoxin 2 expression.

Authors:  Robert M Mitchell; Nuzhath Tajuddin; Edward M Campbell; Edward J Neafsey; Michael A Collins
Journal:  Brain Res       Date:  2016-03-25       Impact factor: 3.252

8.  Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity.

Authors:  Egemen Savaskan; Gianfranco Olivieri; Fides Meier; Erich Seifritz; Anna Wirz-Justice; Franz Müller-Spahn
Journal:  Gerontology       Date:  2003 Nov-Dec       Impact factor: 5.140

9.  Synaptic NMDA receptor activity boosts intrinsic antioxidant defenses.

Authors:  Sofia Papadia; Francesc X Soriano; Frédéric Léveillé; Marc-Andre Martel; Kelly A Dakin; Henrik H Hansen; Angela Kaindl; Marco Sifringer; Jill Fowler; Vanya Stefovska; Grahame McKenzie; Marie Craigon; Roderick Corriveau; Peter Ghazal; Karen Horsburgh; Bruce A Yankner; David J A Wyllie; Chrysanthy Ikonomidou; Giles E Hardingham
Journal:  Nat Neurosci       Date:  2008-03-23       Impact factor: 24.884

10.  Effects of Ethanol on the Expression Level of Various BDNF mRNA Isoforms and Their Encoded Protein in the Hippocampus of Adult and Embryonic Rats.

Authors:  Shahla Shojaei; Saeid Ghavami; Mohammad Reza Panjehshahin; Ali Akbar Owji
Journal:  Int J Mol Sci       Date:  2015-12-21       Impact factor: 5.923

View more
  2 in total

Review 1.  Effects of Peroxiredoxin 2 in Neurological Disorders: A Review of its Molecular Mechanisms.

Authors:  Jifei Liu; Gang Su; Juan Gao; Ye Tian; Xiaoyan Liu; Zhenchang Zhang
Journal:  Neurochem Res       Date:  2020-01-30       Impact factor: 3.996

2.  The Metabolite Urolithin-A Ameliorates Oxidative Stress in Neuro-2a Cells, Becoming a Potential Neuroprotective Agent.

Authors:  Guillermo Cásedas; Francisco Les; Carmen Choya-Foces; Martín Hugo; Víctor López
Journal:  Antioxidants (Basel)       Date:  2020-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.